期刊文献+

左旋氨氯地平治疗老年原发性高血压 被引量:1

Levorotatory amlodipine in treatment of elderly primary hypertension
原文传递
导出
摘要 目的分析左旋氨氯地平治疗老年原发性高血压的临床特点。方法选择老年原发性高血压患者112例,随机分为两组,观察组56例患者给予苯磺酸左旋氨氯地平治疗,对照组56例患者给予苯磺酸氨氯地平治疗,比较两种药物治疗的临床特点、效果及安全性。结果治疗前两组患者血压比较差异无统计学意义,治疗4周、8周后两组收缩压与舒张压均明显下降,治疗前后比较差异有统计学意义,观察组治疗效果好于对照组,两组比较差异有统计学意义(P〈0.05)。观察组不良反应率为3.57%,对照组不良反应率为10.71%,两组比较差异有统计学意义(P〈0.05)。结论左旋氨氯地平治疗老年原发性高血压效果显著,且不良反应明显减少,患者耐受性好。更适合于老年患者服用。 Objective To analyse the clinical characteristics of levorotatory amlodipine in treat- ment of elderly primary hypertension. Methods Choose 112 elderly patients with essential hypertension and randomly divided into two groups. The observation group (56 cases ) were given benzene sulfonic acid levorotatory amlodipine. The treatment group (56 cases) were given benzene sulfonic acid amlodip- ine treatment. Compared the clinical characteristics, effect and safety of the two groups. Results There was no significant difference of the blood pressure between the two groups before treatment. Four and eight weeks after treatment, SBP and DBP dropped significantly after treatment in both groups compared with before treatment. The efficacy of observation group was better than that in the control group, and the difference was significant( P 〈 0.05 ). The adverse reaction rate of observation group was 3.57%, and the control group was 10. 71%, the difference between the two groups was statistical significant( P 〈 0. 05 ). Conclusions The efficacy of levorotatory amlodipine in treatment of elderly primary hyperten- sion is significant, and it can obviously reduce adverse reactions, patients with good tolerance and is more suitable for elderly patients.
作者 王东
出处 《中国实用医刊》 2013年第1期15-16,共2页 Chinese Journal of Practical Medicine
关键词 左旋氨氯地平 原发性高血压 老年 Levorotatory amlodipine Primary hypertension Elderly
  • 相关文献

参考文献4

二级参考文献23

  • 1王薇,赵冬,刘静,孙佳艺,吴桂贤,曾哲淳,刘军,秦兰萍,吴兆苏.中国35~64岁人群血压水平与10年心血管病发病危险的前瞻性研究[J].中华内科杂志,2004,43(10):730-734. 被引量:147
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3[1]Chrysant SG,Fagan T,Glazer R,et al.Effects of benazepril and hydrochlorothiazide,given alone and in low-and highdose combinations,on blood pressure in patients with hypertensioin[J].Arch Fam Med,1996;5:17-24.
  • 4[2]Fogari R,Zoppi A,Tettamanti F,et al.Fixed combination of benazepril and very low dose hydrochlorothiazide in the treatment of mild to moderate essential hypertension:evaluation by 24-hour non invasive ambulatory blood pressure monitoring[J].Int J Clin Pharmacol Ther,1994;32:606-611.
  • 5[3]Holwerda K,Hoogma RP,Oldenbrobk C,et al.Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy[J].Clin Ther,1994:16:942-951.
  • 6Zannad F,Matzinger A,Larche J.Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.Am J Hypertens,1996;9(7):633-643
  • 7Elliott HL,Meredith PA.Trough:peak ratio:clinically useful or practically irrelevant? J Hypertens,1995;13(3):279-283
  • 8Coca A,Calvo C,Sobrino J,et al.Once-daily fixed-combination irbesartan 300mg/hydrochlorothiazide 25mg and circadian blood pressure profile in patients with essential hypertension.Clin Ther,2003;25 (11):2849-2864
  • 9White WB,Lund-Johansen P,Omvik P.Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy.J Hypertens Suppl,1993:11 (4):75-80
  • 10Kochar M,Guthrie R,Triscari J,et al.Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.Am J Hypertens,1999;12(8 Pt 1):797-805

共引文献83

同被引文献4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部